GEMAMEDIC (0885.952.567): financials and annual accounts

GEMAMEDIC

Woluwe-Saint-Pierre ·KBO/BCE: BE 0885.952.567

Line	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
Balance sheet: assets
Total assets`20/58`	758,286	691,055	663,469	452,774	380,193	342,369	139,395	78,684	86,837	123,938	113,006	129,087	49,897	60,629	36,095	52,671	47,314	53,308	56,056
Fixed assets`21/28`	67,675	66,646	63,650	4,331	-	2,939	5,878	-	13,706	27,413	39,596	55,881	5,835	5,545	3,261	460	690	920	-
Tangible fixed assets`22/27`	67,675	66,646	63,650	4,331	-	2,939	5,878	-	13,706	27,413	39,596	55,881	5,835	5,545	3,261	460	690	920	-
Plant, machinery and equipment`23`	19,041	10,052	6,737	2,960	-	-	-	-	3,981	7,962	11,943	17,772	3,697	5,545	3,261	460	690	920	-
Furniture and vehicles`24`	7,047	10,464	17,361	1,371	-	2,939	5,878	-	592	1,183	252	1,574	2,138	-	-	-	-	-	-
Leasing and similar rights`25`	19,940	24,927	29,914	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other tangible fixed assets`26`	21,648	21,203	9,638	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Current assets`29/58`	690,610	624,409	599,819	448,443	380,193	339,431	133,518	78,684	73,130	96,526	73,410	73,206	44,062	55,084	32,834	52,211	46,624	52,388	56,056
Amounts receivable within one year`40/41`	539,092	507,640	448,008	363,310	245,858	201,708	56,501	27,264	6,372	35,155	47,342	51,433	40,792	25,890	28,179	36,972	32,906	40,780	35,006
Trade receivables`40`	12,369	10,994	38,250	68,131	30,294	44,750	44,801	27,264	6,372	8,957	11,143	15,231	14,591	13,917	6,204	6,346	5,433	8,427	3,561
Other amounts receivable`41`	526,723	496,646	409,759	295,180	215,564	156,959	11,700	-	-	26,198	36,199	36,201	26,201	11,974	21,975	30,626	27,474	32,354	31,445
Cash at bank and in hand`54/58`	151,519	116,769	151,810	85,133	134,336	137,722	77,016	4,481	47,383	61,370	25,483	21,177	2,620	26,114	4,017	14,833	12,512	11,460	8,202
Deferred charges and accrued income`490/1`	-	-	-	-	-	-	-	46,938	19,375	-	585	596	650	3,080	639	406	1,206	147	12,848
Balance sheet: equity and liabilities
Total equity and liabilities`10/49`	758,286	691,055	663,469	452,774	380,193	342,369	139,395	78,684	86,837	123,938	113,006	129,087	49,897	60,629	36,095	52,671	47,314	53,308	56,056
Equity`10/15`	129,889	79,219	83,927	20,768	10,954	6,663	21,786	19,473	19,092	40,988	5,874	15,339	26,404	5,266	-14,947	-21,720	-16,328	-71,992	-40,983
Contributions`10/11`	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	6,200	6,200	6,200	6,200	6,200
Issued capital`100`	-	-	-	-	-	-	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600
Uncalled capital`101`	-	-	-	-	-	-	-	-	-	-	-	-	-	0	12,400	12,400	12,400	12,400	12,400
Contributions outside capital`11`	-	-	-	-	-	18,600	-	-	-	-	-	-	-	-	-	-	-	-	-
Share premium`1100/10`	-	-	-	-	-	18,600	-	-	-	-	-	-	-	-	-	-	-	-	-
Reserves`13`	136	136	136	136	136	136	136	20	-	-	-	-	-	-	-	-	-	-	-
Non-distributable reserves`130/1`	136	136	136	136	136	136	-	-	-	-	-	-	-	-	-	-	-	-	-
Legal reserve`130`	-	-	-	-	-	-	136	20	-	-	-	-	-	-	-	-	-	-	-
Reserves not available under the articles`1311`	136	136	136	136	136	136	-	-	-	-	-	-	-	-	-	-	-	-	-
Other`1319`	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-
Profit (loss) carried forward`14`	111,153	60,483	65,191	2,032	-7,782	-12,073	3,050	853	492	22,388	-12,726	-3,261	7,804	-13,334	-21,147	-27,920	-22,528	-78,192	-47,183
Amounts payable`17/49`	628,397	611,836	579,542	432,006	369,239	335,707	117,609	59,210	67,744	82,950	107,132	113,748	23,494	55,363	51,042	74,391	63,642	125,299	97,039
Amounts payable after more than one year`17`	20,971	25,547	30,111	-	-	-	-	-	8,769	22,160	36,012	49,508	-	-	-	-	-	-	-
Financial debts`170/4`	20,971	25,547	30,111	-	-	-	-	-	8,769	22,160	36,012	49,508	-	-	-	-	-	-	-
Amounts payable within one year`42/48`	607,426	586,289	549,431	432,006	369,239	335,707	117,609	58,860	58,975	57,591	68,521	64,240	23,371	53,884	42,191	50,880	43,655	106,219	97,039
Current portion of amounts payable after more than one year`42`	4,802	4,564	4,122	283	-	-	-	8,425	13,390	13,852	13,496	23,150	-	-	-	-	-	-	-
Trade debts`44`	60,550	42,383	62,008	69,289	29,215	108,165	42,493	30,168	28,730	22,497	42,304	29,382	7,605	32,575	22,877	16,467	9,529	72,617	97,039
Suppliers`440/4`	60,550	42,383	62,008	69,289	29,215	108,165	42,493	30,168	28,730	22,497	42,304	29,382	7,605	32,575	22,877	16,467	9,529	72,617	97,039
Taxes, remuneration and social security`45`	43,885	37,653	59,612	24,145	24,638	14,956	26,667	20,268	16,855	21,241	12,721	11,209	15,266	20,808	18,814	11,740	7,677	7,653	-
Taxes`450/3`	12,416	610	26,011	2	3,942	-	-	5,200	1,315	-	-	-	-	-	-	-	-	-	-
Remuneration and social security`454/9`	31,468	37,043	33,600	24,143	20,696	14,956	26,667	15,068	15,540	21,241	12,721	11,209	15,266	20,808	18,814	11,740	7,677	7,653	-
Other amounts payable`47/48`	498,188	501,688	423,688	338,288	315,386	212,586	48,450	-	-	-	-	500	500	500	500	22,673	26,449	25,949	-
Accrued charges and deferred income`492/3`	-	-	-	-	-	-	-	350	-	3,200	2,600	-	123	1,480	8,851	23,510	19,987	19,080	-
Income statement
Turnover`70`	-	-	-	-	-	-	477,305	-	-	-	-	-	-	-	-	-	-	-	-
Non-recurring operating income`76A`	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-
Gross operating margin`9900`	344,787	279,772	341,086	245,453	248,368	175,909	188,823	257,471	216,181	207,620	149,543	122,422	147,556	157,147	137,042	97,670	130,161	31,143	-25,145
Goods, raw materials, services and sundry goods`60/61`	-	-	-	-	-	-	291,974	-	-	-	-	-	-	-	-	-	-	-	-
Remuneration, social security and pensions`62`	243,344	258,318	227,390	225,747	230,280	186,035	182,094	232,515	171,703	155,486	129,575	114,679	120,709	145,977	126,539	102,226	73,037	61,071	20,310
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets`630`	22,837	20,198	18,354	1,426	2,939	2,939	2,939	13,706	13,706	13,959	16,285	16,284	2,917	2,078	988	230	230	230	1,000
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)`631/4`	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,000	-	-	-	-
Other operating charges`640/8`	1,857	534	384	1,310	1,694	365	940	1,872	8,189	348	440	437	462	89	89	89	437	437	437
Non-recurring operating charges`66A`	-	-	853	-	-	-	-	-	26,198	-	0	-	-	-	-	-	-	-	-
Operating profit (loss)`9901`	76,750	722	94,104	16,971	13,455	-13,430	2,849	9,378	-3,615	37,828	3,243	-8,978	23,469	9,002	7,426	-4,875	56,458	-30,594	-46,891
Financial income`75/76B`	-	-	22	20	67	9	0	-	10	2	71	3	67	13	6	8	6	7	3
Recurring financial income`75`	-	-	22	20	67	9	0	-	10	2	71	3	67	13	6	8	6	7	3
Financial charges`65/66B`	1,995	1,881	4,176	859	2,366	1,702	1,361	3,797	2,264	2,365	2,633	2,090	1,058	1,200	660	524	799	421	295
Recurring financial charges`65`	1,995	1,881	4,176	859	2,366	1,702	1,361	3,797	2,264	2,365	2,633	2,090	1,058	1,200	660	524	799	421	295
Profit (loss) for the period before taxes`9903`	74,755	-1,159	89,950	16,131	11,156	-15,124	1,489	5,581	-5,869	35,464	681	-11,065	22,478	7,815	6,773	-5,390	55,665	-31,008	-47,183
Income taxes`67/77`	24,086	3,548	26,790	6,318	6,865	-	-824	5,200	16,027	351	10,146	-	1,340	3	-	1	2	-	1
Profit (loss) for the period`9904`	50,669	-4,708	63,159	9,814	4,292	-15,124	2,313	381	-21,896	35,114	-9,465	-11,065	21,138	7,812	6,773	-5,391	55,663	-31,008	-47,183
Profit (loss) for the period to be appropriated`9905`	50,669	-4,708	63,159	9,814	4,292	-15,124	2,313	381	-21,896	35,114	-9,465	-11,065	21,138	7,812	6,773	-5,391	55,663	-31,008	-47,183
Appropriation of the result
Profit (loss) to be appropriated`9906`	111,153	60,483	65,191	2,032	-7,782	-12,073	3,166	873	492	22,388	-12,726	-3,261	7,804	-13,334	-21,147	-27,920	-22,528	-78,192	-47,183
Profit (loss) brought forward from the previous period`14P`	60,483	65,191	2,032	-7,782	-12,073	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Transfer to equity`691/2`	-	-	-	-	-	-	116	20	-	-	-	-	-	-	-	-	-	-	-
To the legal reserve`6920`	-	-	-	-	-	-	116	20	-	-	-	-	-	-	-	-	-	-	-
Social balance sheet
Average staff (FTE)`9087`	5.5	6.1	4.5	5.1	5.2	4.7	4.2	5.2	4.8	4.3	4.2	3.8	3.6	4.2	4.1	4.1	3	2.3	0.9
Hours worked`1013`	80,870	8,029	7,176	7,887	8,599	7,607	7,274	9,084	8,244	7,584	6,958	6,119	7,569	7,569	6,300	6,341	4,907	3,942	1,668
Document	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF

Financial year	Type	Filed	Reference	Document
31-12-2025	abbreviated format	17-08-2026	2026-00407621	PDF
31-12-2024	full format	21-10-2025	2025-00550625	PDF
31-12-2023	full format	12-08-2024	2024-00351262	PDF
31-12-2022	full format	31-08-2023	2023-00413873	PDF
31-12-2021	full format	26-08-2022	2022-20339279	PDF
31-12-2020	full format	14-07-2021	2021-36000264	PDF
31-12-2019	full format	24-07-2020	2020-34700235	PDF
31-12-2018	micro format	26-08-2019	2019-50500457	PDF
31-12-2017	micro format	30-08-2018	2018-55900553	PDF
31-12-2016	micro format	27-08-2017	2017-52900508	PDF
31-12-2015	full format	15-07-2016	2016-33800139	PDF
31-12-2014	full format	17-07-2015	2015-32000230	PDF
31-12-2013	full format	28-07-2014	2014-36300113	PDF
31-12-2012	full format	29-07-2013	2013-37100601	PDF
31-12-2011	full format	30-07-2012	2012-36100472	PDF
31-12-2010	full format	24-08-2011	2011-42400469	PDF
31-12-2009	full format	06-07-2010	2010-29100157	PDF
31-12-2008	full format	30-07-2009	2009-54300164	PDF
31-12-2007	full format	20-08-2008	2008-58700188	PDF

Line	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
EBITDA	99,587	20,920	112,459	18,397	16,394	-10,491	5,788	23,084	10,091	51,786	19,527	7,307	26,386	11,081	8,414	-4,645	56,688	-30,364	-45,891
Cash flow	73,506	15,490	81,513	11,239	7,230	-12,185	5,252	14,087	-8,189	49,072	6,820	5,220	24,055	9,891	7,761	-5,162	55,893	-30,779	-46,183
Investment in fixed assets (approximation)	23,866	23,194	77,673	5,756	0	0	8,817	0	0	1,775	0	66,330	3,207	4,363	3,789	0	0	1,150	-
Change in cash	34,749	-35,041	66,678	-49,203	-3,387	60,706	72,535	-42,901	-13,988	35,887	4,306	18,557	-23,494	22,097	-10,816	2,321	1,052	3,258	-
Working capital	83,185	38,120	50,388	16,437	10,954	3,724	15,908	19,823	14,155	38,935	4,889	8,966	20,692	1,200	-9,357	1,331	2,969	-53,831	-40,983
EBIT margin	-	-	-	-	-	-	0.6%	-	-	-	-	-	-	-	-	-	-	-	-
Solvency	17.1%	11.5%	12.6%	4.6%	2.9%	1.9%	15.6%	24.7%	22.0%	33.1%	5.2%	11.9%	52.9%	8.7%	-41.4%	-41.2%	-34.5%	-135.0%	-73.1%
Current ratio	1.14	1.07	1.09	1.04	1.03	1.01	1.14	1.34	1.24	1.68	1.07	1.14	1.89	1.02	0.78	1.03	1.07	0.49	0.58
Debt to equity	4.84	7.72	6.91	20.80	33.71	50.39	5.40	3.04	3.55	2.02	18.24	7.42	0.89	10.51	-	-	-	-	-
ROE	39.0%	-5.9%	75.3%	47.3%	39.2%	-227.0%	10.6%	2.0%	-114.7%	85.7%	-161.1%	-72.1%	80.1%	148.4%	-	-	-	-	-
ROA	6.7%	-0.7%	9.5%	2.2%	1.1%	-4.4%	1.7%	0.5%	-25.2%	28.3%	-8.4%	-8.6%	42.4%	12.9%	18.8%	-10.2%	117.6%	-58.2%	-84.2%
Interest coverage	49.91	11.12	26.93	21.40	6.93	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Customer credit	-	-	-	-	-	-	34 days	-	-	-	-	-	-	-	-	-	-	-	-
Supplier credit	-	-	-	-	-	-	53 days	-	-	-	-	-	-	-	-	-	-	-	-

Item	31-12-2025	31-12-2024	31-12-2023	31-12-2022	31-12-2021
Employees at the balance-sheet date	8	9	7	9	7
full-time	3	3	2	2	3
part-time	5	6	5	7	4
in full-time equivalents	5.7	5.9	4.5	5.1	4.9
Average over the year, in full-time equivalents	5.5	6.1	4.5	5.1	5.2
On a permanent contract	8	7	7	7	6
Joined	5	6	-	2	-
Left	6	4	-	2	-

Item	2025	2024	2023	2022	2021
Tangible fixed assets	€23,866	€23,194	€77,673	€5,756	-
Depreciation and write-downs of the year	€22,837	€20,198	€18,354	€1,426	€2,939

GEMAMEDIC

Annual accounts 2025

Money flows

Balance sheet

Change in equityin euro

Change in cashin euro

Position in the sector

Solvency17.1%

Current ratio1.14

Return on assets6.7%

Staff

Staff cost per FTE€44,244

Joined and left-1

Filed annual accounts

Filings

Key figures and ratios

Social balance sheet

Securities and guarantees

Investments

Insights on GEMAMEDIC

Next steps